SCM
LJPC

Sio Capital Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Sio Capital Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,310,367
Closed -$12.1M – 95
2019
Q2 		$12.1M Buy
+1,310,367
New +$9.88M 2.92% 8

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Sio Capital Management's LJPC Position: Q3 2019 in Review

Sio Capital Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2019, closing a stake of 1,310,367 shares — an estimated $12.1M sold.

Sio Capital Management first reported a position in LJPC in Q2 2019 and held it in 1 quarter. The position peaked at $12.1M in Q2 2019. 75 funds tracked by Wall St. Rank hold LJPC as of Q3 2019.

  • Sio Capital Management reported no remaining La Jolla Pharmaceutical Company position as of Q3 2019 after selling out during the quarter.
  • Sio Capital Management sold 1,310,367 La Jolla Pharmaceutical Company shares in Q3 2019, an estimated $12.1M.
  • Sio Capital Management first reported a position in La Jolla Pharmaceutical Company in Q2 2019 and held it in 1 quarter.
  • Sio Capital Management's La Jolla Pharmaceutical Company position peaked at $12.1M in Q2 2019.
  • 75 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2019.

Based on Sio Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.